Aug 21, 2025, 14:59
Primary APS: Warfarin INR 2.5–3.5 Lowers Thrombosis Recurrence, Especially Arterial Events
APS Support UK has shared a post on X:
“Study of 81 pts with primary APS on warfarin found those with INR 2.5–3.5 had reduced rethrombosis risk vs INR <2.5, esp. for arterial events.
Higher anticoagulation intensity = lower recurrence risk.”
Title: Recurrence of thrombosis in patients with primary antiphospholipid syndrome: Emphasis on arterial events
Authors: Antonio R Cabral, Alonso Turrent-Carriles, Irazu Contreras-Yáñez, Ariel Garcia-Torralba, Gabriela Hernandez-Molina
Read the full article here.
Stay updated with Hemostasis Today.
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS
-
Apr 14, 2026, 16:34Hussien Hishmat: Anticoagulation in Pulmonary Embolism
-
Apr 14, 2026, 16:17ASH Is In Search of the Next Team of Authors for the 2026 ASH News Daily